Announcements
- GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
- Appendix 4C & Quarterly Business Update – March 2024
- Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
- Genetic Technologies Announces $2 Million Registered Direct Offering
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
- GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
- GTG to pilot GeneType in Breast Screen centers across the U.S.
- EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
- Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
- GTG Global Collaborations and Innovation Update
More ▼
Key statistics
On Monday, Genetic Technologies Ltd (GNTLF:PKC) closed at 0.0007, -99.00% above its 52-week low of 0.07, set on Nov 06, 2023.
52-week range
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.0007 |
Average volume | -- |
---|---|
Shares outstanding | 132.22m |
Free float | 118.56m |
P/E (TTM) | -- |
Market cap | 15.87m AUD |
EPS (TTM) | -0.1126 AUD |
Data delayed at least 15 minutes, as of Nov 06 2023.
More ▼